| PEB Results of Meeting |
| 24/09/24 | | 120.24KB | Share |
|
| PEB Chair's Address to Shareholders |
| 24/09/24 | | 12.28MB | Share |
|
| PEB Change in substantial holding |
| 19/09/24 | | 142.15KB | Share |
|
| PEB AUA Micro-Hematuria Guideline and Medicare Timelines |
| 13/09/24 | | 109.53KB | Share |
|
| PEB Pacific Edge Chairman Delays Retirement |
| 05/09/24 | | 101.71KB | Share |
|
| PEB Notice of Annual Shareholder Meeting and Proxy Form 2024 |
| 15/08/24 | | 633.94KB | Share |
|
| PEB Novitas Confirms Medicare Coverage Review Extension |
| 29/07/24 | PRICE SENSITIVE | 106.31KB | Share |
|
| PEB Medicare Coverage Determination Still Under Review |
| 26/07/24 | PRICE SENSITIVE | 104.98KB | Share |
|
| PEB Director Nomination Closing Date |
| 16/07/24 | | 52.97KB | Share |
|
| PEB Application for quotation of securities - PEB |
| 11/07/24 | | 16.59KB | Share |
|
| PEB Notification regarding unquoted securities - PEB |
| 11/07/24 | | 15.19KB | Share |
|
| PEB Quarterly Update - Cxbladder Test Volumes Steady in Q1 25 |
| 10/07/24 | PRICE SENSITIVE | 1.59MB | Share |
|
| PEB Notification of cessation of securities - PEB |
| 09/07/24 | | 12.78KB | Share |
|
| PEB Annual Report 2024 |
| 27/06/24 | | 7.37MB | Share |
|
| PEB Cash Burn Slows Coverage Catalysts in Focus |
| 21/05/24 | PRICE SENSITIVE | 15.46MB | Share |
|
| PEB Becoming a substantial holder |
| 01/05/24 | | 95.57KB | Share |
|
| PEB Ceasing to be a substantial holder |
| 01/05/24 | | 79.56KB | Share |
|
| PEB Pacific Edge Full Year Result to be Announced 21 May 2024 |
| 01/05/24 | | 142.94KB | Share |
|
| PEB Clinical Utility of Cxbladder to Headline at AUA 2024 |
| 30/04/24 | | 333.39KB | Share |
|
| PEB Quarterly Update - Cxbladder Test Volumes Steady in Q4 24 |
| 09/04/24 | PRICE SENSITIVE | 1.34MB | Share |
|
| PEB Pacific Edge Directors Give Notice of Retirement |
| 14/03/24 | | 107.17KB | Share |
|
| PEB Cxbladder Test Volumes Correction |
| 22/01/24 | | 1.48MB | Share |
|
| PEB Quarterly Update - Test Volumes Fall Following Restructure |
| 22/01/24 | PRICE SENSITIVE | 1.37MB | Share |
|
| PEB Application for quotation of securities - PEB |
| 15/12/23 | | 25.13KB | Share |
|
| PEB Change in substantial holding |
| 05/12/23 | | 118.74KB | Share |
|
| PEB Financial Results for the Half Year to 30 September 2023 |
| 23/11/23 | PRICE SENSITIVE | 9.85MB | Share |
|
| PEB Kaiser Permanente EMR Integration goes live |
| 15/11/23 | PRICE SENSITIVE | 109.53KB | Share |
|
| PEB Notification regarding unquoted securities - PEB |
| 25/10/23 | | 25.3KB | Share |
|
| PEB NZX - D&O Disclosures - P Meintjes & G Gibson - 25 Oct 23 |
| 25/10/23 | | 934.8KB | Share |
|
| PEB NZX - Capital Change Notice |
| 25/10/23 | | 111.15KB | Share |
|
| PEB Interim Financial Result to be Announced 23 November 2023 |
| 19/10/23 | | 103.6KB | Share |
|
| PEB Notification of cessation of securities - PEB |
| 16/10/23 | | 21.57KB | Share |
|
| PEB Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient |
| 11/10/23 | PRICE SENSITIVE | 1.82MB | Share |
|
| PEB FDA Signals Intent to Regulate Lab Developed Tests |
| 02/10/23 | PRICE SENSITIVE | 120.36KB | Share |
|
| PEB NZX - D&O Disclosures - A Barclay & A Masfen |
| 19/09/23 | | 1.08MB | Share |
|
| PEB Pacific Edge Releases Submissions on Medicare LCD |
| 11/09/23 | | 9.35MB | Share |
|
| PEB NZX - D&O Disclosures - P Meintjes & G Gibson |
| 08/09/23 | | 1.09MB | Share |
|
| PEB Application for quotation of securities - PEB |
| 08/09/23 | | 25.81KB | Share |
|
| PEB NZX - D&O Disclosure - Bryan Williams |
| 08/08/23 | | 414.56KB | Share |
|
| PEB NZX - D&O Disclosures - Chris Gallaher & Grant Gibson |
| 03/08/23 | | 1.08MB | Share |
|
| PEB Letter to Shareholders |
| 28/07/23 | PRICE SENSITIVE | 114.97KB | Share |
|
| PEB Pacific Edge 2023 Annual Shareholder Meeting - Results |
| 27/07/23 | | 104.31KB | Share |
|
| PEB Chair's Address to Shareholders |
| 27/07/23 | | 11.86MB | Share |
|
| PEB Quarterly Update - Q1 24 Test Volumes Reach New Heights |
| 18/07/23 | PRICE SENSITIVE | 1.53MB | Share |
|
| PEB Correction of LCD Reference Number |
| 07/07/23 | | 117.5KB | Share |
|
| PEB Pacific Edge Welcomes Stay of Novitas LCD |
| 06/07/23 | PRICE SENSITIVE | 109.39KB | Share |
|
| PEB Pacific Edge Updates Billing Policies for US Testing |
| 03/07/23 | PRICE SENSITIVE | 306.08KB | Share |
|
| PEB Notice of Annual General Meeting/Proxy Form |
| 26/06/23 | | 702.19KB | Share |
|
| PEB Annual Report to shareholders |
| 22/06/23 | | 5.01MB | Share |
|
| PEB Medicare Coverage of Cxbladder Expected to Cease |
| 07/06/23 | PRICE SENSITIVE | 1.91MB | Share |
|
| PEB Pacific Edge Trading Halt |
| 06/06/23 | PRICE SENSITIVE | 109.31KB | Share |
|
| PEB Trading Halt |
| 05/06/23 | PRICE SENSITIVE | 325.1KB | Share |
|
| PEB Clarification of Novitas Timeline |
| 02/06/23 | PRICE SENSITIVE | 108.53KB | Share |
|
| PEB Pacific Edge Delivers on Growth Strategy in FY 2023 |
| 25/05/23 | PRICE SENSITIVE | 10.17MB | Share |
|
| PEB Director Nomination Closing Date |
| 22/05/23 | | 58.3KB | Share |
|
| PEB Notification regarding unquoted securities - PEB |
| 03/05/23 | | 24.3KB | Share |
|
| PEB Capital Change Notice - NZX |
| 03/05/23 | | 448.61KB | Share |
|
| PEB Pacific Edge Full Year Result to be Announced 25 May 2023 |
| 01/05/23 | | 178.64KB | Share |
|
| PEB Quarterly Update Q4 23 Test Volumes Reach New Record |
| 18/04/23 | PRICE SENSITIVE | 3.09MB | Share |
|
| PEB Pacific Edge Provides Update on Kaiser EMR Integration |
| 31/03/23 | | 199.2KB | Share |
|
| PEB Quarterly Investor Update - Q3 FY23 Test Volumes rise 36% |
| 19/01/23 | PRICE SENSITIVE | 991.27KB | Share |
|
| PEB Te Whatu Ora - Southern Commercial Agreement Completed |
| 13/01/23 | PRICE SENSITIVE | 567.26KB | Share |
|
| PEB Notification regarding unquoted securities - PEB |
| 22/12/22 | | 25.57KB | Share |
|
| PEB Application for quotation of securities - PEB |
| 21/12/22 | | 26.06KB | Share |
|
| PEB Notification of cessation of securities - PEB |
| 21/12/22 | | 21.56KB | Share |
|
| PEB NZX D&O Disclosures - P Meintjes & G Gibson |
| 21/12/22 | | 194.49KB | Share |
|
| PEB Capital Change Notice - NXZ |
| 21/12/22 | | 137.37KB | Share |
|
| PEB Capital Change Notice - NZX |
| 21/12/22 | | 110.87KB | Share |
|
| PEB Enhanced Cxb Tests Deliver Improved Diagnostic Performance |
| 13/12/22 | PRICE SENSITIVE | 226.73KB | Share |
|
| PEB Financial Results for the Half Year to 30 September 2022 |
| 24/11/22 | PRICE SENSITIVE | 9.68MB | Share |
|
| PEB Interim Financial Results to be Announced 24 November 2022 |
| 11/11/22 | | 176.68KB | Share |
|
| PEB Quarterly Investor Update - Q2 FY23 Test Volumes rise 36% |
| 17/10/22 | PRICE SENSITIVE | 1.14MB | Share |
|
| PEB Letter to Shareholders |
| 17/10/22 | | 1.14MB | Share |
|
| PEB Update on Te Whatu Ora Southern Commercial Agreement |
| 23/09/22 | PRICE SENSITIVE | 557.33KB | Share |
|
| PEB PACIFIC EDGE COMMENTS ON PROPOSED NOVITAS LCD |
| 01/08/22 | PRICE SENSITIVE | 673.56KB | Share |
|
| PEB Trading Halt |
| 29/07/22 | PRICE SENSITIVE | 267.2KB | Share |
|
| PEB Pause in Trading |
| 29/07/22 | PRICE SENSITIVE | 115.31KB | Share |
|
| PEB Pacific Edge 2022 Annual Shareholders Meeting - Results |
| 29/07/22 | | 52.05KB | Share |
|
| PEB Pacific Edge 2022 Annual Shareholders Meeting |
| 28/07/22 | | 7.15MB | Share |
|
| PEB Pacific Edge Appoints Chief Operating Officer |
| 28/07/22 | | 169.47KB | Share |
|
| PEB Southern District Health Region Adopts Cxbladder Tests |
| 21/07/22 | PRICE SENSITIVE | 218.92KB | Share |
|
| PEB Pacific Edge Investor Update - Q1 FY23 Test Volumes Rise 32% |
| 20/07/22 | PRICE SENSITIVE | 1.16MB | Share |
|
| PEB Notice of Annual General Meeting/Proxy Form |
| 22/06/22 | | 439.15KB | Share |
|
| PEB Annual Report to shareholders |
| 22/06/22 | | 7.59MB | Share |
|
| PEB Kaiser Permanente agrees to Cxbladder EMR Integration |
| 01/06/22 | PRICE SENSITIVE | 200.51KB | Share |
|
| PEB Pacific Edge LTD FY22 Result |
| 26/05/22 | PRICE SENSITIVE | 5MB | Share |
|
| PEB PEB FY22 Result - NZX Announcement Template |
| 26/05/22 | PRICE SENSITIVE | 127.22KB | Share |
|
| PEB Director Nomination Closing Date |
| 23/05/22 | | 243.85KB | Share |
|
| PEB Clinical Study Advancing Cxbladder as standard of care |
| 10/05/22 | | 681.02KB | Share |
|
| PEB Pacific Edge Full Year Result to be Announced 26 May 2022 |
| 03/05/22 | | 191.76KB | Share |
|
| PEB D&O Disclosure - NZX - D Darling |
| 28/04/22 | | 72.46KB | Share |
|
| PEB Capital Change Notice - NZX |
| 26/04/22 | | 109.84KB | Share |
|
| PEB Application for quotation of securities - PEB |
| 26/04/22 | | 25.21KB | Share |
|
| PEB PEB Investor Update - March 2022 |
| 30/03/22 | | 1.17MB | Share |
|
| PEB Pacific Edge Appoints Tony Barclay to its Board |
| 17/03/22 | | 201.51KB | Share |
|
| PEB Application for quotation of securities - PEB |
| 03/03/22 | | 24.82KB | Share |
|
| PEB Application for quotation of securities - PEB |
| 03/03/22 | | 24.82KB | Share |
|
| PEB Capital Change Notice - NZX |
| 03/03/22 | | 84.42KB | Share |
|
| PEB Notification regarding unquoted securities - PEB |
| 18/02/22 | | 24.63KB | Share |
|
| PEB D&O Disclosure - NZX - Peter Meintjes |
| 18/02/22 | | 187.89KB | Share |
|
(20min delay)
